Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Evaporation Chemistry at ACS

Published: Monday, August 19, 2013
Last Updated: Monday, August 19, 2013
Bookmark and Share
Genevac to display its latest products for productive evaporation in USA.

Genevac has announced that it will display its latest products for productive evaporation at the 246th American Chemical Society meeting and exposition in Indianapolis, Indiana, USA (8th - 12th September 2013).Genevac_PN.gif

Visitors to Booth 2017 will have the chance to see for the first time the ROCKET 4D - a new fully automated system for drying or concentration of very large volumes (a few to 100 litres) in one operation with no user interaction.

Simply load sample, select a method, press start, and walk away - the system will do the rest.

Compact in size the ROCKET 4D allows users to safely dry or concentrate their samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming - problems associated with sample loss when using large scale rotary evaporators.

To download a ROCKET 4D technical brochure, please visit

Specialists will also be on hand to demonstrate and discuss the third generation EZ-2 Series Evaporator - an easy-to-use benchtop system that uses the most advanced proven technology in evaporation science.

The EZ-2 accurately controls vacuum and temperature to enable rapid evaporation of a wide range of solvents and prevent bumping and cross contamination.

Compatible with a wide range of sample holders the EZ-2 will easily integrate within the workflow of many laboratories. Options are available to enable routine, safe removal of potentially explosive solvents such as diethyl ether or pentane and also removal of acids including concentrated hydrochloric acid (HCl).

To download an EZ-2 technical brochure, watch a product video or download applications reports please visit -

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos